Apr 2 (CIDRAP News) The World Health Organization (WHO) today took the unusual step of advising against nonessential travel to Hong Kong and the neighboring Guangdong Province of China because of the outbreak of severe acute respiratory syndrome (SARS) there.
(CIDRAP News) – Federal health officials today released a lengthy plan for dealing with the potentially overwhelming threat of an influenza pandemic like those that occurred three times in the last century.
(CIDRAP News) In a bid to limit the threat of an influenza pandemic, the Department of Health and Human Services (HHS) is awarding a contract to Aventis Pasteur Inc. to make 2 million doses of a vaccine for humans to protect against H5N1 avian influenza.
(CIDRAP News) The British magazine Nature trained a floodlight on the threat of an influenza pandemic today with a collection of 10 articles that explore the danger and possible remedies and demand a more serious global response.
"The level of current efforts is not commensurate with the threat we face," the editors write. "The time for diplomacy and denial is over. It is time for advocacy and action."
(CIDRAP News) International health agencies are questioning China about a report that the country has used a human antiviral drug in poultry for years, thereby causing the H5N1 influenza virus to become resistant to the drug.
(CIDRAP News) – Researchers relying on mathematical modeling claim that early containment of pandemic influenza, an eventuality widely accepted as not an "if" but a "when," may well be attainable through targeted public health strategies. A leading public health expert, however, cautions against viewing these study results as fodder for relaxed planning efforts, stressing the myriad variables that would come into play.
(CIDRAP News) – The outbreak of an unusual pig-related disease in China might be nearly spent, and evidence continued to point to Streptococcus suis as the cause, the World Health Organization (WHO) said yesterday.
Jan 6, 2006 (CIDRAP News) 2005 is likely to go down as the year when avian influenza, powered by a steady rise in human cases and the spread of poultry outbreaks all the way to Eastern Europe, emerged as a high-profile global health issue.
When 2005 dawned, only 45 human cases of H5N1 avian flu, including 32 deaths, had been counted by the World Health Organization (WHO). All of those were in Vietnam and Thailand.
(CIDRAP News) – Low doses of a cell-based avian flu vaccine triggered a good immune response to the H5N1 avian influenza virus, according to preliminary results of a clinical trial by Baxter International of Deerfield, Ill., maker of the vaccine.